Stammdaten
Unternehmen
| Name | Stoke Therapeutics, Inc. |
|---|---|
| Ticker | STOK |
| CIK | 0001623526 |
Branche
| SIC-Code | 2834 |
|---|---|
| Beschreibung | Pharmaceutical Preparations |
Wertpapier
| CUSIP | – |
|---|---|
| ISIN | – |
| Typ | Common Stock |
| Titel | Stoke Therapeutics, Inc. |
Status
| Zuletzt geprüft | 2026-03-22 00:31:09.155323 |
|---|
Fondsaktivität (letzte 3 Quartale)
Keine Fondsdaten für dieses Unternehmen vorhanden.
Insider-Transaktionen (12 Monate)
| Datum | Insider | Rolle | Typ | Stückzahl | Kurs | Wert (USD) | Δ | Trend |
|---|---|---|---|---|---|---|---|---|
| 2026-03-19 | Ticho Barry | Officer, CHIEF MEDICAL OFFICER | Open Market Sale | -1,461 | 29.99 | -43,815.39 | -9,3% | |
| 2026-03-18 | Hoitt Jason | Officer, Chief Patient Officer | Open Market Sale | -30 | 32.85 | -985.50 | -0,2% | |
| 2026-03-18 | Hoitt Jason | Officer, Chief Patient Officer | Open Market Sale | -139 | 31.79 | -4,418.64 | -0,9% | |
| 2026-03-18 | Hoitt Jason | Officer, Chief Patient Officer | Open Market Sale | -1,762 | 31.28 | -55,122.06 | -11,7% | |
| 2026-03-18 | Allan Jonathan | Officer, GENERAL COUNSEL & CORP SEC | Open Market Sale | -4,222 | 31.28 | -132,080.20 | -28,0% | |
| 2026-03-18 | Allan Jonathan | Officer, GENERAL COUNSEL & CORP SEC | Open Market Sale | -72 | 32.85 | -2,365.20 | -0,5% | |
| 2026-03-18 | Hoitt Jason | Officer, Chief Patient Officer | Open Market Sale | -30 | 32.85 | -985.50 | -0,2% | |
| 2026-03-18 | Hoitt Jason | Officer, Chief Patient Officer | Open Market Sale | -139 | 31.79 | -4,418.64 | -0,9% | |
| 2026-03-18 | Hoitt Jason | Officer, Chief Patient Officer | Open Market Sale | -1,762 | 31.28 | -55,122.06 | -11,7% | |
| 2026-03-18 | Leggett Thomas | Officer, Chief Financial Officer | Open Market Sale | -37 | 32.85 | -1,215.45 | -0,3% | |
| 2026-03-18 | Leggett Thomas | Officer, Chief Financial Officer | Open Market Sale | -172 | 31.79 | -5,467.67 | -1,2% | |
| 2026-03-18 | Ticho Barry | Officer, CHIEF MEDICAL OFFICER | Open Market Sale | -103 | 32.85 | -3,383.55 | -0,7% | |
| 2026-03-18 | Ticho Barry | Officer, CHIEF MEDICAL OFFICER | Open Market Sale | -483 | 31.79 | -15,353.99 | -3,3% | |
| 2026-03-18 | Ticho Barry | Officer, CHIEF MEDICAL OFFICER | Open Market Sale | -6,100 | 31.28 | -190,831.18 | -40,4% | |
| 2026-03-18 | Leggett Thomas | Officer, Chief Financial Officer | Open Market Sale | -2,173 | 31.28 | -67,979.70 | -14,4% | |
| 2026-03-18 | Allan Jonathan | Officer, GENERAL COUNSEL & CORP SEC | Open Market Sale | -334 | 31.79 | -10,617.46 | -2,3% | |
| 2026-03-17 | Hoitt Jason | Officer, Chief Patient Officer | Open Market Sale | -748 | 33.38 | -24,964.80 | -5,3% | |
| 2026-03-17 | Allan Jonathan | Officer, GENERAL COUNSEL & CORP SEC | Open Market Sale | -1,791 | 33.38 | -59,775.34 | -12,7% | |
| 2026-03-17 | Allan Jonathan | Officer, GENERAL COUNSEL & CORP SEC | Open Market Sale | -2,476 | 32.74 | -81,062.75 | -17,2% | |
| 2026-03-17 | Leggett Thomas | Officer, Chief Financial Officer | Open Market Sale | -922 | 33.38 | -30,772.12 | -6,5% | |
| 2026-03-17 | Leggett Thomas | Officer, Chief Financial Officer | Open Market Sale | -1,274 | 32.74 | -41,710.00 | -8,8% | |
| 2026-03-17 | Ticho Barry | Officer, CHIEF MEDICAL OFFICER | Open Market Sale | -2,587 | 33.38 | -86,342.16 | -18,3% | |
| 2026-03-17 | Ticho Barry | Officer, CHIEF MEDICAL OFFICER | Open Market Sale | -3,577 | 32.74 | -117,108.83 | -24,8% | |
| 2026-03-17 | Hoitt Jason | Officer, Chief Patient Officer | Open Market Sale | -748 | 33.38 | -24,964.80 | -5,3% | |
| 2026-03-17 | Hoitt Jason | Officer, Chief Patient Officer | Open Market Sale | -1,033 | 32.74 | -33,819.80 | -7,2% | |
| 2026-03-17 | Hoitt Jason | Officer, Chief Patient Officer | Open Market Sale | -1,033 | 32.74 | -33,819.80 | -7,2% | |
| 2026-03-13 | LEVIN ARTHUR A | Director | Open Market Sale | -605 | 36.80 | -22,264.00 | -4,7% | |
| 2026-03-10 | TZIANABOS ARTHUR | Director, Officer, Interim Executive Chair | Open Market Sale | -4,355 | 40.00 | -174,214.37 | -36,9% | |
| 2026-03-10 | Krainer Adrian R. | Director | Open Market Sale | -33,243 | 39.74 | -1,320,963.79 | -279,9% | |
| 2026-03-10 | TZIANABOS ARTHUR | Director, Officer, Interim Executive Chair | Open Market Sale | -4,355 | 40.00 | -174,214.37 | -36,9% | |
| 2026-03-02 | Krainer Adrian R. | Director | Open Market Sale | -7,229 | 39.66 | -286,715.15 | -60,8% | |
| 2025-12-08 | Kaye Edward M. MD | Director | Open Market Sale | -3,825 | 31.44 | -120,253.03 | -25,5% | |
| 2025-12-08 | Allan Jonathan | Officer, GENERAL COUNSEL & CORP SEC | Open Market Sale | -2,678 | 32.61 | -87,337.08 | -18,5% | |
| 2025-12-08 | Kaye Edward M. MD | Director | Open Market Sale | -8,274 | 32.52 | -269,070.48 | -57,0% | |
| 2025-12-08 | Kaye Edward M. MD | Director | Open Market Sale | -1,331 | 33.10 | -44,061.56 | -9,3% | |
| 2025-12-08 | Allan Jonathan | Officer, GENERAL COUNSEL & CORP SEC | Open Market Sale | -1,300 | 31.60 | -41,074.28 | -8,7% | |
| 2025-12-05 | Kaye Edward M. MD | Director | Open Market Sale | -1,681 | 31.15 | -52,357.77 | -11,1% | |
| 2025-12-05 | Allan Jonathan | Officer, GENERAL COUNSEL & CORP SEC | Open Market Sale | -5,437 | 31.08 | -168,997.18 | -35,8% | |
| 2025-12-05 | Allan Jonathan | Officer, GENERAL COUNSEL & CORP SEC | Open Market Sale | -1,004 | 31.33 | -31,455.72 | -6,7% | |
| 2025-12-05 | Kaye Edward M. MD | Director | Open Market Sale | -500 | 31.85 | -15,923.00 | -3,4% | |
| 2025-12-05 | Ticho Barry | Officer, CHIEF MEDICAL OFFICER | Open Market Sale | -1,673 | 31.33 | -52,415.76 | -11,1% | |
| 2025-12-05 | Ticho Barry | Officer, CHIEF MEDICAL OFFICER | Open Market Sale | -1,989 | 31.35 | -62,345.80 | -13,2% | |
| 2025-12-05 | Kaye Edward M. MD | Director | Open Market Sale | -6,367 | 31.33 | -199,480.66 | -42,3% | |
| 2025-12-05 | Allan Jonathan | Officer, GENERAL COUNSEL & CORP SEC | Open Market Sale | -2,344 | 31.76 | -74,444.74 | -15,8% | |
| 2025-12-04 | Kaye Edward M. MD | Director | Open Market Sale | -5,222 | 30.76 | -160,647.00 | -34,0% | |
| 2025-12-04 | Kaye Edward M. MD | Director | Open Market Sale | -1,231 | 31.32 | -38,550.49 | -8,2% | |
| 2025-12-04 | Ticho Barry | Officer, CHIEF MEDICAL OFFICER | Open Market Sale | -323 | 31.32 | -10,115.20 | -2,1% | |
| 2025-12-04 | Allan Jonathan | Officer, GENERAL COUNSEL & CORP SEC | Open Market Sale | -824 | 30.76 | -25,349.12 | -5,4% | |
| 2025-12-04 | Allan Jonathan | Officer, GENERAL COUNSEL & CORP SEC | Open Market Sale | -194 | 31.32 | -6,075.38 | -1,3% | |
| 2025-12-04 | Ticho Barry | Officer, CHIEF MEDICAL OFFICER | Open Market Sale | -1,373 | 30.76 | -42,238.29 | -9,0% | |
| 2025-12-03 | Kaye Edward M. MD | Director | Open Market Sale | -651 | 30.85 | -20,081.85 | -4,3% | |
| 2025-12-03 | Allan Jonathan | Officer, GENERAL COUNSEL & CORP SEC | Open Market Sale | -898 | 30.34 | -27,243.52 | -5,8% | |
| 2025-12-03 | Allan Jonathan | Officer, GENERAL COUNSEL & CORP SEC | Open Market Sale | -1,394 | 30.85 | -43,001.69 | -9,1% | |
| 2025-12-03 | Kaye Edward M. MD | Director | Open Market Sale | -419 | 30.34 | -12,711.62 | -2,7% | |
| 2025-12-03 | Ticho Barry | Officer, CHIEF MEDICAL OFFICER | Open Market Sale | -1,225 | 30.85 | -37,788.43 | -8,0% | |
| 2025-12-03 | Ticho Barry | Officer, CHIEF MEDICAL OFFICER | Open Market Sale | -789 | 30.34 | -23,936.68 | -5,1% | |
| 2025-12-02 | Ticho Barry | Officer, CHIEF MEDICAL OFFICER | Open Market Sale | -1,244 | 29.56 | -36,775.13 | -7,8% | |
| 2025-12-02 | Ticho Barry | Officer, CHIEF MEDICAL OFFICER | Open Market Sale | -762 | 30.14 | -22,968.13 | -4,9% | |
| 2025-12-02 | Allan Jonathan | Officer, GENERAL COUNSEL & CORP SEC | Open Market Sale | -868 | 30.14 | -26,163.17 | -5,5% | |
| 2025-12-02 | Kaye Edward M. MD | Director | Open Market Sale | -661 | 29.56 | -19,540.48 | -4,1% | |
| 2025-12-02 | Kaye Edward M. MD | Director | Open Market Sale | -405 | 30.14 | -12,207.47 | -2,6% | |
| 2025-12-02 | Allan Jonathan | Officer, GENERAL COUNSEL & CORP SEC | Open Market Sale | -1,416 | 29.56 | -41,859.79 | -8,9% | |
| 2025-11-24 | Krainer Adrian R. | Director | Open Market Sale | -40,472 | 29.72 | -1,202,718.57 | -254,9% | |
| 2025-11-14 | Krainer Adrian R. | Director | Open Market Sale | -19,790 | 26.61 | -526,693.04 | -111,6% | |
| 2025-11-14 | Krainer Adrian R. | Director | Open Market Sale | -20,682 | 27.34 | -565,365.22 | -119,8% | |
| 2025-11-03 | Ticho Barry | Officer, CHIEF MEDICAL OFFICER | Open Market Sale | -100 | 29.35 | -2,935.00 | -0,6% | |
| 2025-11-03 | Ticho Barry | Officer, CHIEF MEDICAL OFFICER | Open Market Sale | -600 | 27.54 | -16,524.00 | -3,5% | |
| 2025-11-03 | Ticho Barry | Officer, CHIEF MEDICAL OFFICER | Open Market Sale | -1,455 | 26.02 | -37,859.97 | -8,0% | |
| 2025-11-03 | Ticho Barry | Officer, CHIEF MEDICAL OFFICER | Open Market Sale | -3,776 | 25.22 | -95,246.58 | -20,2% | |
| 2025-10-08 | Kaye Edward M. MD | Director | Open Market Sale | -25,000 | 30.00 | -750,000.00 | -158,9% | |
| 2025-10-03 | Kaye Edward M. MD | Director | Open Market Sale | -42,461 | 25.09 | -1,065,206.37 | -225,7% | |
| 2025-10-03 | Allan Jonathan | Officer, GENERAL COUNSEL & CORP SEC | Open Market Sale | -10,000 | 25.07 | -250,650.00 | -53,1% | |
| 2025-10-01 | Ticho Barry | Officer, CHIEF MEDICAL OFFICER | Open Market Sale | -5,343 | 23.64 | -126,316.00 | -26,8% | |
| 2025-09-03 | Allan Jonathan | Officer, GENERAL COUNSEL & CORP SEC | Open Market Sale | -6,345 | 20.07 | -127,316.87 | -27,0% | |
| 2025-09-03 | Kaye Edward M. MD | Director | Open Market Sale | -45,996 | 20.13 | -925,858.08 | -196,2% | |
| 2025-09-02 | Kaye Edward M. MD | Director | Open Market Sale | -14,860 | 20.14 | -299,259.60 | -63,4% | |
| 2025-09-02 | Ticho Barry | Officer, CHIEF MEDICAL OFFICER | Open Market Sale | -5,501 | 19.87 | -109,325.22 | -23,2% | |
| 2025-09-02 | Allan Jonathan | Officer, GENERAL COUNSEL & CORP SEC | Open Market Sale | -14,922 | 20.14 | -300,491.78 | -63,7% | |
| 2025-08-29 | Kaye Edward M. MD | Director | Open Market Sale | -1,029 | 20.00 | -20,580.00 | -4,4% | |
| 2025-08-29 | Allan Jonathan | Officer, GENERAL COUNSEL & CORP SEC | Open Market Sale | -850 | 20.00 | -17,000.00 | -3,6% | |
| 2025-08-18 | Allan Jonathan | Officer, GENERAL COUNSEL & CORP SEC | Open Market Sale | -1,683 | 18.24 | -30,694.55 | -6,5% | |
| 2025-08-18 | Ticho Barry | Officer, CHIEF MEDICAL OFFICER | Open Market Sale | -2,805 | 18.24 | -51,157.59 | -10,8% | |
| 2025-08-18 | Kaye Edward M. MD | Director | Open Market Sale | -12,126 | 18.24 | -221,153.99 | -46,9% | |
| 2025-08-13 | Allan Jonathan | Officer, GENERAL COUNSEL & CORP SEC | Open Market Sale | -13,712 | 15.00 | -205,680.00 | -43,6% | |
| 2025-08-01 | Ticho Barry | Officer, CHIEF MEDICAL OFFICER | Open Market Sale | -4,504 | 12.82 | -57,724.16 | -12,2% | |
| 2025-07-01 | Ticho Barry | Officer, CHIEF MEDICAL OFFICER | Open Market Sale | -4,503 | 11.63 | -52,379.35 | -11,1% | |
| 2025-06-04 | Skorpios Trust | 10% Owner | Open Market Sale | -3,000,000 | 10.20 | -30,600,000.00 | -6484,7% | |
| 2025-06-03 | Ticho Barry | Officer, CHIEF MEDICAL OFFICER | Open Market Sale | -6,471 | 10.03 | -64,892.48 | -13,8% | |
| 2025-06-02 | Ticho Barry | Officer, CHIEF MEDICAL OFFICER | Open Market Sale | -1,745 | 10.00 | -17,450.00 | -3,7% | |
| 2025-05-02 | Ticho Barry | Officer, CHIEF MEDICAL OFFICER | Open Market Sale | -22,790 | 10.03 | -228,542.68 | -48,4% | |
| 2025-05-01 | Ticho Barry | Officer, CHIEF MEDICAL OFFICER | Open Market Sale | -3,841 | 10.00 | -38,410.00 | -8,1% |
Top-Fondshalter (aktuelles Quartal)
Keine Fondsdaten für das aktuelle Quartal vorhanden.